This episode is a discussion between ⁠Rahmad Akbar, Senior Data Scientist in Antibody Design at Novo Nordisk and Murat Tunaboylu⁠, Co-Founder and CEO of Antiverse⁠.

You will learn:

The impact antibody design has on the world. How AI is helping to push antibody design forward, bringing new therapies to patients. What will antibody design look like in the future?


Rahmad's LinkedIn page.

Rahmad's Personal Website.

Antibody Origami: Here.

Rahmad's Previous and Existing Team: Victor Greiff (GreiffLab). Paolo Marcatili, Ludovica Beltrame, Rasmus Høiberg-Nielsen (Antibody Design at Novo Nordisk).


"And a big shout out to budding antibody designers (scientists) everywhere especially from my home country Indonesia!' - Rahmad.

Be sure to like, rate and review the podcast if you enjoyed this episode!

Visit our website: https://www.antiverse.io/

Follow us:

LinkedIn:⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/antiverse/⁠⁠⁠⁠⁠⁠⁠

X: ⁠⁠⁠⁠⁠⁠⁠https://twitter.com/AntiverseHQ⁠⁠

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Murat Tunaboylu. Innehållet i podden är skapat av Murat Tunaboylu och inte av, eller tillsammans med, Poddtoppen.